Christopher Burke

Christopher Burke Email and Phone Number

Principal Scientist, Translational Genetics at AbbVie @ AbbVie
Christopher Burke's Location
Boston, Massachusetts, United States, United States
Christopher Burke's Contact Details

Christopher Burke personal email

n/a
About Christopher Burke

Molecular and cellular neuroscientist with ten years of drug discovery experience. Demonstrated ability to drive early-stage programs in both small and large biotech companies. Expertise in identifying and investigating biological pathways relevant to neurodegenerative disease. Effective communicator, collaborator and team leader.

Christopher Burke's Current Company Details
AbbVie

Abbvie

View
Principal Scientist, Translational Genetics at AbbVie
Christopher Burke Work Experience Details
  • Abbvie
    Principal Scientist
    Abbvie Aug 2024 - Present
    North Chicago, Illinois, Us
    Cerevel Therapeutics was acquired by AbbVie on August 1, 2024.
  • Cerevel Therapeutics
    Principal Scientist
    Cerevel Therapeutics Jul 2023 - Aug 2024
    North Chicago, Illinois, Us
  • Pfizer
    Principal Scientist
    Pfizer Sep 2022 - Jun 2023
    New York, New York, Us
  • Yumanity Therapeutics
    Senior Scientist
    Yumanity Therapeutics Jul 2019 - Jul 2022
    • Senior Scientist in Discovery Biology, utilizing patient-derived iPSC and cell line models to validate small molecule targets relevant to neurodegenerative disease. Conducted biochemical and imaging-based experiments to assay changes in Parkinson's Disease and ALS-relevant phenotypes.• Led an early-stage discovery program for a dual ALS/ Parkinson’s Disease target. Early successful efforts led to nomination of target for additional resources.• Assessed tissue samples from preclinical animal studies for putative target engagement and efficacy biomarkers of Parkinson’s Disease. • Managed and mentored two direct reports (Associate and Scientist level) to advance early discovery programs.• Designed and managed external projects performed at CROs.• Member of the Mammalian Biology Target Validation Team, played an active role in helping guide target selection and validation for our portfolio.
  • Forma Therapeutics, Inc.
    Senior Scientist - Neuroscience/ Discovery Biology
    Forma Therapeutics, Inc. Mar 2019 - Jun 2019
    Watertown, Massachusetts, Us
    A core member of the Neurodegenerative Disease team, working to validate and advance target programs, develop assays to interrogate small molecule inhibitors and guide exploratory target selection for the NDD portfolio• Established and optimized assays to measure modulation of Parkinson’s Disease (PD) and ALS-related phenotypes in cell culture models using multiple high-content imaging and biochemistry approaches. Developed workflows to routinely screen small molecules• Developed and optimized activity probe and HTRF-based assays to measure compound target engagement in cell lines and ex-vivo brain samples. Built correlational analyses for our assays to support medicinal chemistry• Led Forma’s collaboration with SITraN, University of Sheffield, UK to profile compounds in PD/ ALS patient-derived neurons and coordinated external experiments done at the Oxford Drug Discovery Institute, Oxford, UK as part of a larger collaboration• Presented data at internal and external scientific meetings and to collaborators• Directly managed and mentored associate scientists to advance target programs including one direct report
  • Forma Therapeutics, Inc.
    Scientist
    Forma Therapeutics, Inc. Aug 2017 - Feb 2019
    Watertown, Massachusetts, Us
  • Biogen
    Postdoctoral Scientist
    Biogen Oct 2013 - Aug 2017
    Cambridge, Ma, Us
    Investigated the role of novel modulators of Parkinson’s Disease (PD) pathology using mammalian cell culture and Drosophila. Mentors: Subhabrata Sanyal Ph.D. and Warren Hirst Ph.D• Established Drosophila degenerative and cognitive behavioral assays, cell and biochemistry-based assays for autophagy and imaging based assays• Co-led cross-departmental team around an exploratory drug target for PD, Coordinated and directed monthly meetings with members of Biology, Medicinal Chemistry, Epigenetics, Research Technology and Molecular Therapeutics to guide exploration into target biology and drugability• Established and maintained scientific collaborations both internally and externally• Techniques include: mammalian cell culture, transfection, electroporation, SiRNA, viral vectors, Drosophila genetics, and behavioral assays, neurodegenerative assays, immunohistochemistry, high-throughput RNAi screens, RNASeq and analysis, molecular biology, qRTPCR, WB, CO-IP, drug dosing in cells and flies, PLA
  • Umass Medical School
    Doctoral Candidate
    Umass Medical School Sep 2008 - Jun 2013
    Worcester, Ma, Us
    Delineated the neural circuit mechanisms underlying reinforcement of appetitive memory in Drosophila. Mentor: Scott Waddell, Ph.D.• Extensive fly genetics and molecular biology to manufacture and verify strains for behavioral and anatomical analysis, as well as confocal microscopy and live-imaging of intracellular calcium.• Implemented the use of non-metabolizable sugars and nutritious supplements as reinforcing stimuli in olfactory classical conditioning in Drosophila.• Developed new assays to quantify survival, ingestion and palatability.• Developed new “artificial learning” behavioral paradigms to study reinforcement signaling using state of the art thermogenetic tools.
  • Children'S Hospital Boston
    Research Associate
    Children'S Hospital Boston Jun 2005 - Aug 2008
    Boston, Ma, Us
    Performed experiments screening for genetic and chemical enhancers and modifiers in a zebrafish model of melanoma. Lab of Leonard Zon, M.D. Hematology/Oncology Department• Techniques include PCR, molecular cloning, large-scale sequencing and genotyping, embryonic microinjection, transgenesis, RT-PCR, DNA and RNA purification from tissue samples, live-imaging and fluorescence microscopy.• Responsible for zebrafish husbandry, feeding, breeding and maintenance of over 60 genetic lines.

Christopher Burke Skills

Neuroscience Behavioral Neuroscience Animal Behavior Genetics Molecular Cloning Western Blotting Immunohistochemistry Fluorescence Microscopy In Vivo Cell Culture Cell Biology Confocal Microscopy Lifesciences Molecular Biology Pcr Microscopy Laboratory Life Sciences Polymerase Chain Reaction Biochemistry

Christopher Burke Education Details

  • Umass Chan Medical School
    Umass Chan Medical School
    Biomedical Science - Neuroscience
  • Boston College
    Boston College
    Biology/Biological Sciences

Frequently Asked Questions about Christopher Burke

What company does Christopher Burke work for?

Christopher Burke works for Abbvie

What is Christopher Burke's role at the current company?

Christopher Burke's current role is Principal Scientist, Translational Genetics at AbbVie.

What is Christopher Burke's email address?

Christopher Burke's email address is cb****@****ity.com

What schools did Christopher Burke attend?

Christopher Burke attended Umass Chan Medical School, Boston College.

What skills is Christopher Burke known for?

Christopher Burke has skills like Neuroscience, Behavioral Neuroscience, Animal Behavior, Genetics, Molecular Cloning, Western Blotting, Immunohistochemistry, Fluorescence Microscopy, In Vivo, Cell Culture, Cell Biology, Confocal Microscopy.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.